Catheter ablation for persistent atrial fibrillation (AF) is associated with less favorable outcomes than for paroxysmal AF. Substrate modification is often added to pulmonary vein isolation (PVI) to try to improve success rates. Recent studies have shown improved clinical outcomes with use of regional ablation index (AI) targets for PVI. We hypothesized that prospective use of AI-guided PVI in persistent AF patients would result in a low rate of PV reconnection at repeat electrophysiology study and that a high success rate can be achieved with durable PVI alone.
C
omplete pulmonary vein isolation (PVI) has been recommended as the best-established target for ablation of paroxysmal atrial fibrillation (AF) and has been found to be noninferior to more extensive ablation in persistent atrial fibrillation (PeAF). [1] [2] [3] Late recovery of ablated tissue has been the Achilles' heel of radiofrequency ablation, with late reconnection of at least 1 PV reported in ≈70% of patients even after complete acutely successful PVI. 1 The introduction of contact force (CF)-sensing catheters and use of forcetime integral (FTI)-targeted ablation has improved results, but not to the levels hoped for, with 38% to 62% of patients still showing late PV reconnection. 4, 5 Ablation index (AI) is a novel marker of ablation lesion quality that incorporates power, CF, and time in a weighted formula and was found to accurately estimate ablation lesion depth in preclinical studies. 6 The AI formula is proprietary and is shown below with the constants replaced with letters. That formula has been recently integrated as an ablation lesion quality monitoring module into the automated lesion tagging software (VisiTag) in the CARTO 3 V4 3D electroanatomic mapping system (Biosense Webster, Inc, Diamond Bar, CA). A multicenter retrospective study and a prospective study involving protocol-mandated repeat procedures after 2 months defined the minimum regional AI target values that would be required to prevent acute PV reconnection in the former study and late PV reconnection in the latter study, as 550 for anterior and roof and 400 for posterior and inferior left atrial (LA) segments. 5, 7 We hypothesized that prospective use of these AI targets would result in a low rate of PV reconnection and that durable PVI alone may be adequate to achieve a high rate of clinical success in patients with PeAF. We, therefore, designed the PRAISE study (Pulmonary Vein Reconnection Following Ablation Index-Guided Ablation: a Success Evaluation), in which 40 patients underwent a protocol-mandated repeat electrophysiology procedure following AI-guided ablation to determine the prevalence of late PV reconnection. Patients were then monitored intensively >12-month follow-up period for clinical outcomes.
METHODS
The data, analytic methods, and study materials have been made available to other researchers for purposes of reproducing the results or replicating the procedure.
The study population comprised 40 consecutive patients with PeAF, of <12 months duration, and with no significant structural heart disease who underwent AI-guided PVI at 3 sites: Liverpool Heart and Chest Hospital, Liverpool, United Kingdom; Freeman Hospital, Newcastle upon Tyne, United Kingdom; and Centro Cardiologico Monzino, Milan, Italy. The study was registered prospectively: PRAISE. The study was approved by the individual Institutional and National Ethics Committees, as well as monitored by a Data Monitoring and Safety Committee. Each patient provided written informed consent before participation.
Initial Ablation Procedure
All procedures were performed under general anesthesia or deep conscious sedation. Vitamin K antagonist treatment was uninterrupted while non-Vitamin K anticoagulants were omitted on the morning of the procedure. After ultrasound-guided right femoral venous access, 8 2 transseptal punctures were performed using fluoroscopic guidance with additional pressure monitoring, after which intravenous unfractionated heparin boluses were administered to maintain an activated clotting time of >300 seconds. If the patient was in AF, electric cardioversion was performed to restore sinus rhythm. A 3-dimensional navigation system (CARTO 3, Biosense Webster, Inc, Diamond Bar, CA) was used to create a 3-dimensional electroanatomical voltage map of the LA, with integration with a computed tomography or magnetic resonance imaging reconstruction of the LA (CartoMerge, Biosense Webster, Inc) where available.
PVI was performed with radiofrequency energy in a pointby-point wide area circumferential ablation (WACA) pattern using a Thermocool SmartTouch irrigated tip CF-sensing
WHAT IS KNOWN?
• Ablation index is a novel marker incorporating contact force, time, and power in a weighted formula.
• Retrospective analysis found that the minimum ablation index value within a segment of the encircling pulmonary vein isolation lesion is predictive of pulmonary vein reconnection in that segment at repeat electrophysiology study and that higher values were required for durable isolation in anterior/ roof segments compared with posterior/inferior segments.
WHAT THE STUDY ADDS?
• Ablation index regional targets-guided ablation results in high rate of durable pulmonary vein isolation at repeat electrophysiology study, with 93% of pulmonary veins found to remain durably isolated.
• Late reconnection is the most commonly encountered in carinal regions, and, therefore, consideration needs to be given to ablating these regions preemptively.
• An ablation index-guided pulmonary vein isolation-only strategy provides a high rate of clinical success in patients with persistent atrial fibrillation with no significant structural heart disease, potentially because of improved durability of pulmonary vein isolation.
ablation catheter (Biosense Webster, Inc) introduced via a nonsteerable sheath. The WACAs were created >10 mm outside the PV ostia, where the local electrograms did not show near-field PV signals. For the left pulmonary veins, ablation was performed just inside the ridge anterior to the veins. Ablation on the intervenous carinae was not delivered as part of initial lesion set, unless it was needed to achieve PVI. None of the patients received additional ablation in the left atrium, and the only other additional ablation permitted was cavotricuspid isthmus ablation for documented typical atrial flutter.
The VisiTag settings for all 40 patients were as follows: catheter position stability: minimum time 10 seconds, maximum range 2 mm; force over time: 30%, minimum force 5 g; and lesion tag size: 2 mm. The protocol required that the operator should aim to deliver contiguous lesions (center-tocenter distance ≤6 mm). 9 A CF of 5 to 40 g was targeted at each site. Power settings were at the individual operator's discretion within the range of 20 to 40 W depending on the LA segment. Each lesion was guided by AI targets: 550 at the roof and anterior walls and 400 at the posterior and inferior walls ( Figure 1) . 10 Impedance drop and FTI data were neither displayed nor targeted. Esophageal temperature monitoring was performed in all general anesthesia cases, and radiofrequency delivery was stopped as soon as the esophageal temperature reached 39°C, even if the target AI value of 400 had not been reached. Further radiofrequency was not delivered on the posterior wall until the esophageal temperature reached baseline level. If there was evidence of residual conduction into the PVs on the posterior wall after completion of the WACA, radiofrequency was delivered inside the WACA, that is, further away from the esophagus, as shown in Figure 2 .
The acute end point of the procedure was complete PVI, as demonstrated by entrance block using a 20-pole circular mapping catheter (Lasso NAV Eco; Biosense Webster, Inc) placed sequentially in each of the PVs. After a minimum of 20 minutes from the last ablation to that WACA lesion set, ipsilateral PVs were rechecked with the Lasso catheter to determine if spontaneous PV reconnection had occurred, and these sites were tagged. If overt PV reconnection had not occurred, a bolus of intravenous adenosine (12-18 mg) was administered to unmask any sites of dormant conduction. Further ablation was performed at any sites of overt or unmasked reconnection to achieve PVI once again.
Repeat Electrophysiology Study
All patients underwent protocol-mandated repeat procedure, regardless of AF recurrence, 8 to 10 weeks after the initial procedure. Periprocedural anticoagulation management and procedural protocol were identical to the first procedure, including creation of a LA map using CARTO and integration with the original computed tomography or magnetic resonance imaging reconstruction of the LA, where available. Each PV was then assessed in turn for late reconnection with a Lasso catheter and reconnection sites were recorded. All reconnection sites were reablated using a Thermocool SmartTouch irrigated ablation catheter until PVI was successfully achieved. The same AI target values as for the initial procedure (550 for the roof and anterior wall and 400 for the posterior and inferior walls) were used, as safety data for higher AI values than these are not available.
If the patient remained in AF after achieving isolation of all PVs, electric cardioversion was performed. No additional ablation was performed.
ECG Follow-Up
All patients were provided with a validated portable ECG monitor (Omron HCG-801-E, Omron Healthcare, Kyoto, Japan). 11 After training them in its use, patients were instructed to self record a 30 seconds ECG every day and additionally whenever they experienced symptoms. ECG recordings were downloaded at each follow-up visit and were analyzed for the presence and dates of any atrial tachyarrhythmia (AT) by experienced clinicians blinded to patient symptoms.
Patient Follow-Up
Follow-up visits were arranged after 6 weeks and 3, 6, and 12 months. Any antiarrhythmic medications, including β blockers, were stopped 3 months after the initial ablation unless substantial AT continued to occur beyond 3 months. The validated AF effect on quality of life questionnaire, which includes 20 questions across 3 domains (symptoms, daily activities, and treatment concerns) using a 7-point Likert scale, was completed at baseline and at 6 and 12 months.
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Study Outcomes
The primary outcome measure was freedom from AT recurrence after the 3-month blanking period after the initial ablation procedure. AT recurrence was defined as documented AF, atrial flutter, or atrial tachycardia lasting ≥30 seconds. 13 Secondary outcome measures were as follows: quality of life 6 and 12 months after initial ablation; time to first AT recurrence; AT burden during the primary outcome period; reinitiation of antiarrhythmic medication; and the occurrence of major complications.
Per-Protocol Analysis
The occurrence of any of the following was regarded as a protocol violation and the relevant WACA circle/patient was excluded from PV reconnection data analysis: any technical problem that prevented the delivery of the full ablation lesion set during the initial ablation procedure; if the initial ablation lesion set was not delivered in a WACA pattern (>1 cm outside the PV ostia); or the presence of >8 gaps (defined as an interlesion distance of >6 mm) in a WACA circle. 
Ablation Lesion Data Analysis
All patients underwent detailed offline retrospective analyses of each of their WACA circle ablation lesions. The data for each VisiTag included ablation duration, CF, impedance drop, FTI, and AI. CF was defined as the mean CF during ablation, and impedance drop as the difference between the preablation impedance value and the lowest recorded value during ablation. The CARTO 3 system automatically calculates FTI and AI values for each lesion. FTI is calculated by multiplication of the mean CF during energy application by the duration of the application and is measured in gram-seconds (gs). AI is calculated using a complex weighted exponential formula allocating different weights to CF, time, and power. 6 To analyze the effect of using different AI target values for the various LA regions, each WACA circle was divided into 6 potential reconnection segments (roof, 2 anterior, inferior, and 2 posterior). We then categorized these 6 segments into 2 regions per WACA circle according to the regional AI targets used for AI-group: anterior and posterior regions (Figure 1 ).
Statistical Analysis
Continuous variables are presented as mean and SD or median and interquartile range (25th-75th percentiles) where appropriate. Student t test or the Mann-Whitney U test was used for unpaired group comparison. Categorical variables were compared by χ 2 or Fisher exact test and are presented as frequency and percentage. All tests were 2-sided, and a P<0.05 was considered statistically significant.
Statistical analysis was performed using SPSS (version 24, IBM Corp, Armonk, NY).
RESULTS
The demographic and procedural data for the 40 patients are presented in Table 1 . As the patient cohort comprises patients with PeAF, the mean LA size was relatively large at 43±5 mm and LV function was impaired in 8 (20%) of patients. The median duration of PeAF was 9.5 (6-12) months, and 28/40 (70%) patients had undergone at least 1 attempt of electric cardioversion before the initial PVI. All 40 patients returned for repeat study, and no major complications occurred in any of the 80 procedures.
A total of 2764 VisiTags was analyzed with a mean number of 69±12 VisiTags per patient. The mean ablation time was 36±9 minutes, and the mean CF was 13±2 g.
Four WACAs (2 left sided and 2 right sided), with the relevant 4 patients, 8 PVs, and 24 segments, were excluded from PV reconnection analysis because of protocol violation: 2 because of the presence of >8 gaps in the WACA circle, 1 because segmental ostial (rather than WACA) PVI was performed, and 1 because of equipment failure.
Acute PV Isolation and Acute Reconnection
All of the 147 PVs included for analysis were successfully isolated. A carina line to achieve PV isolation was required in 9/76 (12%) WACAs in 9/36 (25%) patients. After the 20-minute waiting period and the use of adenosine, acute reconnection was seen in 10 (28%) patients affecting 14 (10%) PVs (Table 2) . Acute reconnection occurred in 15 (3%) segments, the majority of 
Late PV Reconnection at Repeat Electrophysiology Study
The mean interval between the initial PVI procedure and repeat electrophysiology study was 64±6 days. Late PV reconnection was identified in 13 (3%) segments in 8 (22%) patients, affecting 11 (7%) PVs (Table 2 ). All reconnected PVs in the 8 patients with late PV reconnection were successfully reisolated. The median ablation time required for reisolation was 5.6 (4.5-7.9) minutes. The distribution of segments with late reconnection is shown in Figure 3 (Lower). 
Relationship Between Acute and Late PV Reconnection
AI Values for Reconnected Versus Nonreconnected Segments
There was no significant difference in the minimum AI values for segments with acute reconnection compared with those without, either for anterior/roof regions (566 
PV Reconnection in Relation to PV Anatomy
Intervenous Carina Ablation A carina ablation line for reisolation was needed in 4/10 (40%) of the acute reconnected WACAs. Similarly, there was a need for a carina ablation line at repeat study to reisolate 4/8 (50%) of the late reconnected WACA circles (Figure 3 ). In total, 16/76 (21%) WACA circles (10 right sided and 6 left sided) in 16/36 (44%) patients required a carina line at some point during the 2 procedures.
Esophageal Proximity to PVs
During the initial PVI procedures, an esophageal temperature rise of >39°C was encountered in 12 patients affecting 14 posterior segments (7 right and 7 left), necessitating premature termination of radiofrequency energy application before the AI target of 400 was reached (Figure 2 ). The highest recorded peak esophageal temperature during ablation on the LA posterior wall was 40.4°C. The incidence of acute reconnection was significantly higher in the posterior segments where esophageal temperature rise was detected (4/14 [29%]), compared with the posterior segments where there was no such rise (4/62 [6%]; P=0.015).
After successful reisolation of these acutely reconnected segments, there was no significant difference in the incidence of late reconnection between posterior segments that were or were not affected by esophageal temperature rise ( 
Recurrence of AT
No patient was lost to follow-up, and patient compliance with the daily handheld ECG recording was excellent. A total of 14 424 ECG recordings were obtained and analyzed. The median number of ECGs recorded during the 12-month follow-up period was 372 (342-405) recording per patient, with 100 (89-107) recorded during the blanking period, and 270 (240-302) recorded during the primary outcome period.
In the period between the end of blanking period and the end of 12-month follow-up, AT recurrence was documented in 8/40 (20%) patients (Figure 4) , only 1 of whom had late reconnection at repeat study. AT recurrence was in a paroxysmal pattern in 5 (62.5%) patients (of whom 3 patients had AT documented on a single day only) and in a persistent pattern requiring electric cardioversion in 3 (37.5%) patients. The median time to first AT recurrence 184 (133-191) days, and the AT burden during the primary outcome period was 11 (1-48) days. By the end of the 12-month follow-up period, 38 (95%) patients were in sinus rhythm, with only 4 (10%) patients taking antiarrhythmic drugs or β-blockers. Freedom from AT recurrence was not significantly different between patients who needed redo ablation for PV reconnection, and those who had no reconnection (75% versus 81%; P=0.69). Table 3 presents patient demographics and clinical characteristics of patients with and without AT recurrence. Higher body mass index and excess alcohol intake, defined as >30 g/wk, were the only 2 factors significantly associated with AT recurrence during the outcome period.
Patient Characteristics in Relation to AT Recurrence
Early Recurrence of AT
During the blanking period, early recurrence of AT occurred in 12 (30%) of patients. Only 2 patients with early recurrence of AT required redo ablation for PV reconnection at repeat study and neither had further AT recurrence during the study follow-up period. Of the 10 remaining patients with early recurrence of AT but no PV reconnection, 4 went on to have postblanking period AT, indicating a non-PV driver for their recurrent AT. The absence of early recurrence of AT during the blanking period was significantly associated with freedom from late recurrence of atrial tachyarrhythmia at 12 months (85.7% versus 66.7%; P<0.01).
AF Effect on Quality of Life Scores
For all patients at 6 months after the initial PVI procedure, AF effect on quality of life scores showed a highly significant improvement in patient quality of life compared with baseline (63. 
DISCUSSION Main Findings
This study is the first to investigate the durability of PVI after AI-guided ablation, as assessed at protocol-mandated repeat electrophysiology study, and clinical outcomes at 12 months after a PVI only strategy in patients with PeAF. The main findings of this study are (1) AIguided ablation was associated with high rate of durable PVI of 93% PVs in a PeAF population; (2) around onethird of posterior segments where therapeutic AI values could not be reached because of a rise in esophageal temperature exhibited acute PV reconnection after the 20-minute waiting period; (3) almost half of patients in the AI-group required ablation on the intervenous carina to achieve permanent PVI; (4) an AI-guided PVI only ablation strategy was associated with a successful outcome in the vast majority of patients >12 months, most probably because of more durable PVI; and (5) higher body mass index and excess alcohol consumption were significantly associated with AT recurrence.
Reduction of Acute and Late Reconnection
Experiments in an animal model have suggested that AI accurately predicts the depth of ablation lesions, 6 and AI has, therefore, been proposed as a novel marker of ablation lesion quality. Previous retrospective analysis of VisiTag data in a multicenter retrospective study identified minimum AI values of 540 and 380 that were predictive of freedom from acute reconnection in the anterior/ roof and posterior/inferior regions, respectively. 7 In our previously-published CF-guided paroxysmal AF ablation trial, the PRESSURE trial (Pulmonary Vein Re-Isolation as a Routine Strategy: a Success Rate Evaluation), similar AI values were also found to predict freedom from late reconnection at protocol-mandated repeat procedure after 2 months. 5 Although the ablation protocol used in both studies was virtually identical with the exception of the use of AI targets in this study, the study populations are different which limits direct comparisons, though enrollment of PeAF patients with larger LA size in the present study would be expected to confer a disadvantage. Nevertheless, the prospective use of AI target values in the current study resulted in a substantial reduction in the proportion of acutely reconnected WACA circles (13% versus 26%), late reconnected WACA circles (11% versus 35%), and patients with late reconnection (22% versus 62%) compared with CF-guided ablation in the PRESSURE trial.
14 These findings indicate that AI-guided ablation results in more durable PVI.
These results are consistent with our previous findings that the use of this strategy is associated with a significant reduction in AT recurrence compared with CF-guided ablation, possibly because of creation of better quality lesions as suggested by a greater impedance drop. 10 Recently, Taghji et al 15 have also demonstrated excellent clinical results with the use of AI-guided PVI in a cohort of patients with paroxysmal AF. The wider reproducibility of this strategy is now being tested in a multicenter study of paroxysmal AF patients (URL: https://www.clinicaltrials.gov. Unique identifier: NCT03062046).
Despite the reduction in acute reconnection with AIguided ablation, a predilection for this phenomenon was still seen in the right posterior regions. This finding may be related in part to the inability to deliver therapeutic lesions (AI target of 400) on the posterior LA wall whenever a significant rise in the esophageal temperature was encountered during the initial radiofrequency ablation.
Carinal Ablation
There was a greater need for carinal ablation, especially on the right side, to achieve initial PVI, and the intervenous carinae were also common sites for both acute and late reconnection. This is likely to be related to the relatively large LA size in the study group, and may also be explained by a recent study using computed tomography that demonstrated that the carinae are the thickest segments of the PV-LA junction. 16 Because around half of WACA circles required carina ablation overall, routine ablation of the carinal regions, especially on the right side, could be considered a necessary part of the WACA lesion set in patients with PeAF. This may be of particular importance in cases where attempts at delivering therapeutic lesions are thwarted by esophageal temperature rise, or where the right WACA circle is particularly wide because of anatomic reasons such as presence of a dilated left atrium. We think that the overall improvement in the acute and late reconnection rates with AI-guided ablation along the circumferential WACA lesion sets allowed identification of unablated carinae as the weak links in achieving permanent PVI. It is notable that each carinal region is obligatorily ablated twice during cryoballoon PVI, and this may partly account for the high durable PVI rates described with this technology.
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Overall Relationship Between Acute and Late PV Reconnection With AI-Guided Ablation
In keeping with previous findings, 14 the proportion of segments with acute reconnection that exhibited late reconnection at repeat study was not different from the proportion of segments that did not exhibit acute reconnection at the initial procedure, indicating effective reablation at these segments. However, the proportion of PVs with acute reconnection that exhibited late reconnection was significantly higher than the proportion of PVs without acute reconnection. These findings suggest that even with the use of AI-guided ablation, there may be an additional impediment to delivering effective ablation in some PeAF patients, such as the presence of thicker or more fibrotic tissue. This merits further investigation.
High Incidence of Durable PVI With a Single Procedure
A few previous studies have studied patients with a protocol-mandated repeat electrophysiology study 2 to 3 months after PVI to investigate the prevalence of late PV reconnection (Table 4) . The percentage of patients with late reconnection of at least 1 PV was 60% to 70% in studies where CF information was not available, 1, 18 or where CF-sensing catheters were used without FTI target values. 20 In the EFFICAS II study, where a minimum FTI target of 400 gs globally was used to guide ablation, this was reduced to 38%, but the increased efficacy came at the expense of serious complications (tamponade) in 8.3%. 4 Our durable PVI rate of 93% with the use of regional AI targets is the highest reported, and this was achieved without any complications. The durability of PVI in our study is comparable to the small single-center SUPIR study (Sustained PV Isolation With Arctic Front Advance) in which at least two 4-minute freezes were delivered to each PV with the second-generation cryoballoon. 17 However, patients included in that study had paroxysmal AF, with presumably smaller left atria, there was a 3/21 (14.3%) complication rate and 2/21 (9%) drop-out rate, and assessment for late reconnection was solely with a circular catheter. A subsequent study of the second-generation cryoballoon, in which a single 3-minute freeze was delivered to each PV, showed considerably higher rates of late reconnection affecting 27% of PVs in 66% of patients when assessed by both a circular mapping catheter and electroanatomical mapping, as in our study. 19 Considering the fact that a strategy of a routine repeat procedure at 2 months is not feasible in routine clinical practice, the 12-month arrhythmia-free success rate of 81% in patients who did not require ablation at the repeat procedure (n=28) was equivalent to those who required repeat ablation (n=12). This singleablation procedure outcome is superior to the 66.7% arrhythmia-free single-procedure success rate at 12 months using PVI only in PeAF patients seen in a recently published systematic review, 21 and likely represents an estimate of what is achievable with a durable WACAbased PVI. Moreover, these results are also consistent with our previously reported results from a wider clinical cohort, albeit in whom the intensity of ECG monitoring during follow-up was not as intensive as in this study. 
Factors Associated With Late AT Recurrence
Patients in our study with late AT recurrence after catheter ablation were found to have a higher body mass index and a greater proportion consumed excess alcohol (>30 g/wk), findings which are consistent with previous work. 22, 23 Our study findings, therefore, support recommendations to pursue healthy lifestyle modifications, such as weight reduction and avoidance of excess alcohol, to facilitate rhythm control after AF ablation.
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Limitations
The study is not a randomized controlled study and, therefore, direct comparisons with CF-guided ablation cannot be made. Second, despite the absence of complications in this study across the 3 centers, the study size is too small to provide definitive safety assessment of AI-guided ablation strategy. However, between January 2015 and April 2018, we at Liverpool Heart and Chest Hospital have performed 542 AF ablation procedures guided by AI targets for 385 de novo and 157 redo cases. In these cases, the following major complications were observed: 2 cardiac tamponades (both caused by LA perforation with the mapping catheter before application of RF energy), 2 hematomas delaying hospital discharge, and 1 transient ischemic attack with full neurological recovery. There were no cases of phrenic nerve palsy, atrioesophageal fistula, or stroke. These findings are also consistent with our recently published early experience with AF ablation guided by these same AI targets. 10 Four WACAs, and the corresponding 4 patients, had to be excluded from detailed CARTO analysis because of protocol violation; however, we have presented clinical results data for the whole cohort of 40 patients. Finally, in the absence of continuous ECG monitoring, it is possible that brief asymptomatic episodes were missed, thereby overestimating clinical success rates.
Conclusions
AI regional target-guided ablation results in a low rate of PV reconnection at repeat electrophysiology study, with 93% of PVs found to remain durably isolated. Late reconnection was most commonly encountered in carinal regions, and, therefore, consideration needs to be given to ablating these regions preemptively. An AIguided PVI only strategy in patients with persistent AF of <12 months duration, and with no significant structural heart disease provides a high rate of clinical success, potentially because of improved durability of PVI.
